Los puntos clave no están disponibles para este artículo en este momento.
The worldwide emergence of multiresistant ESBL-producing E. coli raises key therapeutic problems; interventions addressed to their quick detection and early appropriate antibiotic treatment and prevention are urgently needed.
Oteo et al. (Tue,) studied this question.